ArticleFrontiers in oncology2022

High efficacy of azacitidine combined with homoharringtonine, idarubicin, and cytarabine in newly diagnosed patients with AML: A single arm, phase 2 trial.

Jun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.